RICHARD PAUL BRYCE Insider Trading $PBYI PUMA BIOTECHNOLOGY, INC.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for RICHARD PAUL BRYCE.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of RICHARD PAUL BRYCE. RICHARD PAUL BRYCE is SEE REMARKS in PUMA BIOTECHNOLOGY, INC. ($PBYI) and SR VP, CLINICAL RESEARCH & DEV in PUMA BIOTECHNOLOGY, INC. ($PBYI).
RICHARD PAUL BRYCE in PUMA BIOTECHNOLOGY, INC.
Trading Symbol: PBYIIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of RICHARD PAUL BRYCE: SEE REMARKS, SR VP, CLINICAL RESEARCH & DEV
Holdings: 121,662 shares
Current Value: $4,118,259
Latest Transaction: Apr 06 2021
$PBYI Market Capitalization: $1.37B
$PBYI Previous Close: $33.85
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of RICHARD PAUL BRYCE in PUMA BIOTECHNOLOGY, INC.
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Apr 06 2021 | PBYI | PUMA BIOTECHNOLOGY ... | BRYCE RICHARD PAUL | SEE REMARKS | Sell | S | 9.80 | 426 | 4,176 | 121,662 | 122.1 K to 121.7 K (-0.35 %) |
Mar 04 2021 | PBYI | PUMA BIOTECHNOLOGY ... | BRYCE RICHARD PAUL | SEE REMARKS | Sell | S | 10.15 | 422 | 4,283 | 122,088 | 122.5 K to 122.1 K (-0.34 %) |
Feb 19 2021 | PBYI | PUMA BIOTECHNOLOGY ... | BRYCE RICHARD PAUL | SEE REMARKS | Option Exercise | A | 12.02 | 74,341 | 893,579 | 74,341 | |
Feb 19 2021 | PBYI | PUMA BIOTECHNOLOGY ... | BRYCE RICHARD PAUL | SEE REMARKS | Grant | A | 0.00 | 52,846 | 0 | 122,510 | 69.7 K to 122.5 K (+75.86 %) |
Feb 03 2021 | PBYI | PUMA BIOTECHNOLOGY ... | BRYCE RICHARD PAUL | SEE REMARKS | Sell | S | 12.23 | 415 | 5,076 | 69,664 | 70.1 K to 69.7 K (-0.59 %) |
Dec 04 2020 | PBYI | PUMA BIOTECHNOLOGY ... | BRYCE RICHARD PAUL | SEE REMARKS | Sell | S | 11.65 | 92 | 1,072 | 76,627 | 76.7 K to 76.6 K (-0.12 %) |
Oct 05 2020 | PBYI | PUMA BIOTECHNOLOGY ... | BRYCE RICHARD PAUL | SEE REMARKS | Sell | S | 10.14 | 91 | 923 | 76,816 | 76.9 K to 76.8 K (-0.12 %) |
Sep 03 2020 | PBYI | PUMA BIOTECHNOLOGY ... | BRYCE RICHARD PAUL | SEE REMARKS | Sell | S | 9.77 | 90 | 879 | 76,907 | 77 K to 76.9 K (-0.12 %) |
Aug 05 2020 | PBYI | PUMA BIOTECHNOLOGY ... | BRYCE RICHARD PAUL | SEE REMARKS | Sell | S | 10.80 | 86 | 929 | 76,997 | 77.1 K to 77 K (-0.11 %) |
Jul 06 2020 | PBYI | PUMA BIOTECHNOLOGY ... | BRYCE RICHARD PAUL | SEE REMARKS | Sell | S | 10.67 | 660 | 7,040 | 77,083 | 77.7 K to 77.1 K (-0.85 %) |
Jun 03 2020 | PBYI | PUMA BIOTECHNOLOGY ... | BRYCE RICHARD PAUL | SEE REMARKS | Sell | S | 10.66 | 89 | 949 | 77,743 | 77.8 K to 77.7 K (-0.11 %) |
May 06 2020 | PBYI | PUMA BIOTECHNOLOGY ... | BRYCE RICHARD PAUL | SEE REMARKS | Sell | S | 9.62 | 89 | 856 | 77,832 | 77.9 K to 77.8 K (-0.11 %) |
Apr 03 2020 | PBYI | PUMA BIOTECHNOLOGY ... | BRYCE RICHARD PAUL | SEE REMARKS | Sell | S | 7.37 | 91 | 671 | 77,921 | 78 K to 77.9 K (-0.12 %) |
Apr 03 2020 | PBYI | PUMA BIOTECHNOLOGY ... | BRYCE RICHARD PAUL | SEE REMARKS | Sell | S | 7.37 | 91 | 671 | 77,921 | 78 K to 77.9 K (-0.12 %) |
Feb 13 2020 | PBYI | PUMA BIOTECHNOLOGY ... | BRYCE RICHARD PAUL | SEE REMARKS | Option Exercise | A | 12.34 | 54,842 | 676,750 | 54,842 | |
Feb 13 2020 | PBYI | PUMA BIOTECHNOLOGY ... | BRYCE RICHARD PAUL | SEE REMARKS | Grant | A | 0.00 | 43,274 | 0 | 78,108 | 34.8 K to 78.1 K (+124.23 %) |
Feb 04 2020 | PBYI | PUMA BIOTECHNOLOGY ... | BRYCE RICHARD PAUL | SEE REMARKS | Sell | S | 8.02 | 105 | 842 | 34,834 | 34.9 K to 34.8 K (-0.30 %) |
Dec 03 2019 | PBYI | PUMA BIOTECHNOLOGY ... | BRYCE RICHARD PAUL | SEE REMARKS | Sell | S | 10.34 | 83 | 858 | 36,455 | 36.5 K to 36.5 K (-0.23 %) |
Nov 05 2019 | PBYI | PUMA BIOTECHNOLOGY ... | BRYCE RICHARD PAUL | SEE REMARKS | Sell | S | 7.38 | 88 | 649 | 36,538 | 36.6 K to 36.5 K (-0.24 %) |
Oct 03 2019 | PBYI | PUMA BIOTECHNOLOGY ... | BRYCE RICHARD PAUL | SEE REMARKS | Sell | S | 10.05 | 91 | 915 | 36,626 | 36.7 K to 36.6 K (-0.25 %) |
Sep 05 2019 | PBYI | PUMA BIOTECHNOLOGY ... | BRYCE RICHARD PAUL | SEE REMARKS | Sell | S | 10.11 | 95 | 960 | 36,717 | 36.8 K to 36.7 K (-0.26 %) |
Sep 05 2019 | PBYI | PUMA BIOTECHNOLOGY ... | BRYCE RICHARD PAUL | SEE REMARKS | Sell | S | 10.11 | 95 | 960 | 36,717 | 36.8 K to 36.7 K (-0.26 %) |
Aug 05 2019 | PBYI | PUMA BIOTECHNOLOGY ... | BRYCE RICHARD PAUL | SEE REMARKS | Sell | S | 9.00 | 94 | 846 | 36,812 | 36.9 K to 36.8 K (-0.25 %) |
Jul 24 2019 | PBYI | PUMA BIOTECHNOLOGY ... | BRYCE RICHARD PAUL | SEE REMARKS | Sell | S | 10.10 | 1,841 | 18,589 | 36,906 | 38.7 K to 36.9 K (-4.75 %) |
Jul 03 2019 | PBYI | PUMA BIOTECHNOLOGY ... | BRYCE RICHARD PAUL | SEE REMARKS | Sell | S | 12.78 | 89 | 1,137 | 38,747 | 38.8 K to 38.7 K (-0.23 %) |
Jun 05 2019 | PBYI | PUMA BIOTECHNOLOGY ... | BRYCE RICHARD PAUL | SEE REMARKS | Sell | S | 15.07 | 88 | 1,326 | 38,836 | 38.9 K to 38.8 K (-0.23 %) |
May 06 2019 | PBYI | PUMA BIOTECHNOLOGY ... | BRYCE RICHARD PAUL | SEE REMARKS | Sell | S | 32.38 | 85 | 2,752 | 38,924 | 39 K to 38.9 K (-0.22 %) |
Apr 03 2019 | PBYI | PUMA BIOTECHNOLOGY ... | BRYCE RICHARD PAUL | SEE REMARKS | Sell | S | 35.78 | 88 | 3,149 | 39,009 | 39.1 K to 39 K (-0.23 %) |
Mar 22 2019 | PBYI | PUMA BIOTECHNOLOGY ... | BRYCE RICHARD PAUL | SEE REMARKS | Sell | S | 38.66 | 88 | 3,402 | 39,097 | 39.2 K to 39.1 K (-0.22 %) |
Mar 22 2019 | PBYI | PUMA BIOTECHNOLOGY ... | BRYCE RICHARD PAUL | SEE REMARKS | Sell | S | 38.66 | 88 | 3,402 | 39,097 | 39.2 K to 39.1 K (-0.22 %) |
Feb 08 2019 | PBYI | PUMA BIOTECHNOLOGY ... | BRYCE RICHARD PAUL | SEE REMARKS | Option Exercise | A | 27.76 | 15,400 | 427,504 | 15,400 | |
Feb 08 2019 | PBYI | PUMA BIOTECHNOLOGY ... | BRYCE RICHARD PAUL | SEE REMARKS | Grant | A | 0.00 | 9,900 | 0 | 39,185 | 29.3 K to 39.2 K (+33.81 %) |
Feb 06 2019 | PBYI | PUMA BIOTECHNOLOGY ... | BRYCE RICHARD PAUL | SEE REMARKS | Sell | S | 27.77 | 89 | 2,472 | 29,285 | 29.4 K to 29.3 K (-0.30 %) |
Jan 24 2019 | PBYI | PUMA BIOTECHNOLOGY ... | BRYCE RICHARD PAUL | SEE REMARKS | Sell | S | 24.72 | 1,959 | 48,426 | 29,374 | 31.3 K to 29.4 K (-6.25 %) |
Jan 04 2019 | PBYI | PUMA BIOTECHNOLOGY ... | BRYCE RICHARD PAUL | SEE REMARKS | Sell | S | 20.67 | 1,210 | 25,011 | 31,333 | 32.5 K to 31.3 K (-3.72 %) |
Jul 24 2018 | PBYI | PUMA BIOTECHNOLOGY ... | BRYCE RICHARD PAUL | SEE REMARKS | Sell | S | 51.95 | 1,836 | 95,381 | 32,543 | 34.4 K to 32.5 K (-5.34 %) |
Feb 13 2018 | PBYI | PUMA BIOTECHNOLOGY ... | BRYCE RICHARD PAUL | SEE REMARKS | Option Exercise | A | 60.85 | 14,000 | 851,900 | 14,000 | |
Feb 13 2018 | PBYI | PUMA BIOTECHNOLOGY ... | BRYCE RICHARD PAUL | SEE REMARKS | Grant | A | 0.00 | 9,000 | 0 | 34,379 | 43.4 K to 34.4 K (-20.75 %) |
Jan 24 2018 | PBYI | PUMA BIOTECHNOLOGY ... | BRYCE RICHARD PAUL | SR VP, CLINICAL RES ... | Sell | S | 92.75 | 1,860 | 172,515 | 25,379 | 27.2 K to 25.4 K (-6.83 %) |
Oct 02 2017 | PBYI | PUMA BIOTECHNOLOGY ... | BRYCE RICHARD PAUL | SR VP, CLINICAL RES ... | Option Exercise | M | 11.30 | 15,000 | 169,500 | 67,000 | |
Oct 02 2017 | PBYI | PUMA BIOTECHNOLOGY ... | BRYCE RICHARD PAUL | SR VP, CLINICAL RES ... | Sell | S | 120.00 | 15,000 | 1,800,000 | 27,239 | 42.2 K to 27.2 K (-35.51 %) |
Oct 02 2017 | PBYI | PUMA BIOTECHNOLOGY ... | BRYCE RICHARD PAUL | SR VP, CLINICAL RES ... | Buy | M | 11.30 | 15,000 | 169,500 | 42,239 | 27.2 K to 42.2 K (+55.07 %) |
Sep 08 2017 | PBYI | PUMA BIOTECHNOLOGY ... | BRYCE RICHARD PAUL | SR VP, CLINICAL RES ... | Option Exercise | M | 11.30 | 14,000 | 158,200 | 82,000 | |
Sep 08 2017 | PBYI | PUMA BIOTECHNOLOGY ... | BRYCE RICHARD PAUL | SR VP, CLINICAL RES ... | Option Exercise | M | 11.30 | 1,000 | 11,300 | 96,000 | |
Sep 08 2017 | PBYI | PUMA BIOTECHNOLOGY ... | BRYCE RICHARD PAUL | SR VP, CLINICAL RES ... | Sell | S | 100.10 | 14,000 | 1,401,400 | 27,239 | 41.2 K to 27.2 K (-33.95 %) |
Sep 08 2017 | PBYI | PUMA BIOTECHNOLOGY ... | BRYCE RICHARD PAUL | SR VP, CLINICAL RES ... | Buy | M | 11.30 | 14,000 | 158,200 | 41,239 | 27.2 K to 41.2 K (+51.40 %) |
Sep 08 2017 | PBYI | PUMA BIOTECHNOLOGY ... | BRYCE RICHARD PAUL | SR VP, CLINICAL RES ... | Sell | S | 100.00 | 1,000 | 100,000 | 27,239 | 28.2 K to 27.2 K (-3.54 %) |
Sep 08 2017 | PBYI | PUMA BIOTECHNOLOGY ... | BRYCE RICHARD PAUL | SR VP, CLINICAL RES ... | Buy | M | 11.30 | 1,000 | 11,300 | 28,239 | 27.2 K to 28.2 K (+3.67 %) |
Jul 24 2017 | PBYI | PUMA BIOTECHNOLOGY ... | BRYCE RICHARD PAUL | SR VP, CLINICAL RES ... | Sell | S | 95.20 | 7 | 666 | 27,239 | 27.2 K to 27.2 K (-0.03 %) |
Jul 24 2017 | PBYI | PUMA BIOTECHNOLOGY ... | BRYCE RICHARD PAUL | SR VP, CLINICAL RES ... | Sell | S | 94.48 | 1,991 | 188,111 | 27,246 | 29.2 K to 27.2 K (-6.81 %) |
Jul 14 2017 | PBYI | PUMA BIOTECHNOLOGY ... | BRYCE RICHARD PAUL | SR VP, CLINICAL RES ... | Option Exercise | M | 11.30 | 5,000 | 56,500 | 97,000 | |
Jul 14 2017 | PBYI | PUMA BIOTECHNOLOGY ... | BRYCE RICHARD PAUL | SR VP, CLINICAL RES ... | Sell | S | 87.10 | 5,000 | 435,500 | 29,237 | 34.2 K to 29.2 K (-14.60 %) |
Jul 14 2017 | PBYI | PUMA BIOTECHNOLOGY ... | BRYCE RICHARD PAUL | SR VP, CLINICAL RES ... | Buy | M | 11.30 | 5,000 | 56,500 | 34,237 | 29.2 K to 34.2 K (+17.10 %) |
Feb 21 2017 | PBYI | PUMA BIOTECHNOLOGY ... | BRYCE RICHARD PAUL | SR VP, CLINICAL RES ... | Option Exercise | A | 37.35 | 31,500 | 1,176,525 | 31,500 | |
Jan 24 2017 | PBYI | PUMA BIOTECHNOLOGY ... | BRYCE RICHARD PAUL | SR VP, CLINICAL RES ... | Sell | S | 33.24 | 2,293 | 76,208 | 29,237 | 31.5 K to 29.2 K (-7.27 %) |
Oct 14 2016 | PBYI | PUMA BIOTECHNOLOGY ... | BRYCE RICHARD PAUL | SR VP, CLINICAL RES ... | Grant | A | 0.00 | 31,500 | 0 | 31,530 | 30 to 31.5 K (+105,000.00 %) |
May 27 2016 | PBYI | PUMA BIOTECHNOLOGY ... | BRYCE RICHARD PAUL | SR VP, CLINICAL RES ... | Option Exercise | A | 35.61 | 41,250 | 1,468,913 | 41,250 | |
Aug 04 2015 | PBYI | PUMA BIOTECHNOLOGY ... | BRYCE RICHARD PAUL | SR VP, CLINICAL RES ... | Option Exercise | A | 87.88 | 31,500 | 2,768,220 | 31,500 | |
Jul 08 2015 | PBYI | PUMA BIOTECHNOLOGY ... | BRYCE RICHARD PAUL | SR VP, CLINICAL RES ... | Option Exercise | M | 11.30 | 3,000 | 33,900 | 102,000 | |
Jul 08 2015 | PBYI | PUMA BIOTECHNOLOGY ... | BRYCE RICHARD PAUL | SR VP, CLINICAL RES ... | Sell | S | 110.03 | 3,000 | 330,084 | 30 | 3 K to 30 (-99.01 %) |
Jul 08 2015 | PBYI | PUMA BIOTECHNOLOGY ... | BRYCE RICHARD PAUL | SR VP, CLINICAL RES ... | Buy | M | 11.30 | 3,000 | 33,900 | 3,030 | 30 to 3 K (+10,000.00 %) |
May 21 2015 | PBYI | PUMA BIOTECHNOLOGY ... | BRYCE RICHARD PAUL | SR VP, CLINICAL RES ... | Buy | P | 82.49 | 28 | 2,310 | 30 | 2 to 30 (+1,400.00 %) |
May 21 2015 | PBYI | PUMA BIOTECHNOLOGY ... | BRYCE RICHARD PAUL | SR VP, CLINICAL RES ... | Buy | P | 87.35 | 2 | 175 | 2 | 0 to 2 |
Jul 10 2014 | PBYI | PUMA BIOTECHNOLOGY ... | BRYCE RICHARD PAUL | SR VP, CLINICAL RES ... | Option Exercise | A | 65.66 | 31,500 | 2,068,290 | 31,500 | |
Jul 11 2013 | PBYI | PUMA BIOTECHNOLOGY ... | BRYCE RICHARD PAUL | SR VP, CLINICAL RES ... | Option Exercise | A | 55.20 | 36,750 | 2,028,600 | 36,750 | |
Jun 28 2012 | PBYI | PUMA BIOTECHNOLOGY ... | BRYCE RICHARD PAUL | SR VP, CLINICAL RES ... | Option Exercise | A | 11.30 | 105,000 | 1,186,500 | 105,000 |
Page: 1